Which has grown faster, SUPN or UFPT?

Over the past five years, UFPT grew revenue faster — SUPN at a 7.78% CAGR versus UFPT at 27.47%.

Is SUPN or UFPT more profitable?

UFPT runs the higher net margin — SUPN at -13.23% versus UFPT at 11.45%.

How have SUPN and UFPT total returns compared?

Over the past 10 years, SUPN delivered 5.87% and UFPT delivered 27.76% annualized total return. Past performance doesn't predict future results.

Supernus Pharmaceuticals, Inc. (SUPN) vs UFP Technologies, Inc. (UFPT)

A side-by-side comparison of Supernus Pharmaceuticals, Inc. and UFP Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

SUPN

Supernus Pharmaceuticals, Inc.

$2.49B

$42.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

UFPT

UFP Technologies, Inc.

$2.34B

$302.87HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — SUPN vs UFPT

growth of $100 · dividends reinvested · last 10y

SUPN +79.4% (+6.0%/yr)UFPT +1068.1% (+27.9%/yr)UFPT compounded faster over this window

Log scale — wide-divergence pair

SUPN UFPT

SUPN vs UFPT: by the numbers

•SUPN is the larger company ($2.49B vs $2.34B market cap).
•UFPT is profitable (11.45% net margin) while SUPN runs a net loss (-13.23%).
•UFPT grew revenue faster over the past five years (27.47% vs 7.78% CAGR).

Metrics side by side

Valuation

Metric	SUPN	UFPT
P/E ratio	N/A	32.67
Forward P/E	16.70	31.09
PEG ratio	N/A	0.87
P/S ratio	2.99	3.71
P/B ratio	2.41	5.07
EV / EBITDA	N/A	20.54
FCF yield	0.76%	2.62%

Profitability

Metric	SUPN	UFPT
Gross margin	88.07%	28.50%
Operating margin	-5.13%	15.25%
Net margin	-13.23%	11.45%
ROE	-10.66%	15.63%
ROIC	-10.24%	12.75%

Growth (annualized)

Metric	SUPN	UFPT
Revenue CAGR (5Y)	7.78%	27.47%
EPS CAGR (5Y)	N/A	37.73%
FCF CAGR (5Y)	-30.77%	26.87%
Total return CAGR (5Y)	9.85%	37.11%

Frequently asked

Which has grown faster, SUPN or UFPT?: Over the past five years, UFPT grew revenue faster — SUPN at a 7.78% CAGR versus UFPT at 27.47%.
Is SUPN or UFPT more profitable?: UFPT runs the higher net margin — SUPN at -13.23% versus UFPT at 11.45%.
How have SUPN and UFPT total returns compared?: Over the past 10 years, SUPN delivered 5.87% and UFPT delivered 27.76% annualized total return. Past performance doesn't predict future results.

Go deeper

Full SUPN analysis Full UFPT analysis Interactive comparison tool

Dig into the metrics

UFP Technologies P/E ratio Supernus Pharmaceuticals ROE UFP Technologies ROE Supernus Pharmaceuticals operating margin UFP Technologies operating margin Supernus Pharmaceuticals revenue growth UFP Technologies revenue growth Supernus Pharmaceuticals free cash flow UFP Technologies free cash flow

Supernus Pharmaceuticals & UFP Technologies appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.